rs142920070
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001080463.2(DYNC2H1):āc.12664A>Cā(p.Ile4222Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,595,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001080463.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.12664A>C | p.Ile4222Leu | missense_variant | 88/90 | ENST00000650373.2 | NP_001073932.1 | |
DYNC2H1 | NM_001377.3 | c.12643A>C | p.Ile4215Leu | missense_variant | 87/89 | ENST00000375735.7 | NP_001368.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000650373.2 | c.12664A>C | p.Ile4222Leu | missense_variant | 88/90 | NM_001080463.2 | ENSP00000497174 | A1 | ||
DYNC2H1 | ENST00000375735.7 | c.12643A>C | p.Ile4215Leu | missense_variant | 87/89 | 1 | NM_001377.3 | ENSP00000364887 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000894 AC: 136AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000211 AC: 46AN: 217750Hom.: 0 AF XY: 0.000154 AC XY: 18AN XY: 116942
GnomAD4 exome AF: 0.0000797 AC: 115AN: 1443070Hom.: 0 Cov.: 30 AF XY: 0.0000684 AC XY: 49AN XY: 715856
GnomAD4 genome AF: 0.000900 AC: 137AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000859 AC XY: 64AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 20, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.12664A>C (p.I4222L) alteration is located in exon 88 (coding exon 88) of the DYNC2H1 gene. This alteration results from a A to C substitution at nucleotide position 12664, causing the isoleucine (I) at amino acid position 4222 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Asphyxiating thoracic dystrophy 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 24, 2022 | - - |
Jeune thoracic dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
DYNC2H1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 27, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at